Skip to main content
Clinical Trials/NL-OMON28560
NL-OMON28560RecruitingNot Applicable

THE MUSCLE POWER STUDY: Surgery related muscle loss and muscle strength after complex abdominal surgery for pseudomyxoma peritonei, pancreatic, liver and colorectal cancer

This work is supported by a grant from the UMCG Cancer Research Foundation (Institutional Foundation for Cancer Research and Development). The study protocol has not undergone any peer-review by this funding body, nor will they play a role in the analysis and interpretation of the data.0 sites178 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
178

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a patient must meet all of the following inclusion criteria:
  • Age = 18 years;
  • Able to read and understand the Dutch language;
  • Diagnosed or the suspicion of a liver tumor (primary cancer or colorectal liver metastases), pancreatic malignancy, bile duct malignancy, colon tumor, rectum tumor, or pseudomyxoma peritonei;
  • Scheduled to undergo elective open major abdominal surgery at UMCG, consisting of the following surgical procedures:
  • ocytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy (CRS with HIPEC);
  • o(sub)total pelvic exenteration;
  • opylorus preserving pancreaticoduodenectomy (PPPD);
  • owhipple procedure (classic pancreaticoduodenectomy);
  • o(sub)total pancreatectomy; or
  • omajor liver resection defined as =3 liver segments.
  • Presence of a preoperative computed tomography (CT) of the abdomen to determine sarcopenia preoperatively;
  • Has given informed consent to participate in the study.

Exclusion Criteria

  • A potential eligible patient who meets any of the following exclusion criteria will be excluded from participation in this study:
  • Scheduled to undergo emergency resection;
  • Scheduled to undergo laparoscopic surgery;
  • Scheduled to undergo minor liver resections (defined as <3 liver segments);
  • Inability to co-operate and give informed consent.

Investigators

Sponsor
This work is supported by a grant from the UMCG Cancer Research Foundation (Institutional Foundation for Cancer Research and Development). The study protocol has not undergone any peer-review by this funding body, nor will they play a role in the analysis and interpretation of the data.

Similar Trials

THE MUSCLE POWER STUDY: Surgery related... | Clinical Trial